triamcinolone acetonide has been researched along with Cranial Nerve II Injuries in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chang, CH; Huang, TL; Lin, KH; Sheu, MM; Tsai, RK | 1 |
1 other study(ies) available for triamcinolone acetonide and Cranial Nerve II Injuries
Article | Year |
---|---|
Lack of protective effect of local administration of triamcinolone or systemic treatment with methylprednisolone against damages caused by optic nerve crush in rats.
Topics: Administration, Topical; Animals; Blotting, Western; Cell Count; Ectodysplasins; Evoked Potentials, Visual; Extracellular Signal-Regulated MAP Kinases; Glucocorticoids; In Situ Nick-End Labeling; Injections, Intraperitoneal; Methylprednisolone Hemisuccinate; Nerve Crush; Nerve Degeneration; Neuroprotective Agents; Optic Nerve; Optic Nerve Injuries; Proto-Oncogene Proteins c-akt; Rats; Retinal Ganglion Cells; STAT3 Transcription Factor; Triamcinolone Acetonide | 2011 |